Key result
A systematic review of 5 studies found limited Smart Home Technology available for cardiovascular disease management, with all included studies focusing exclusively on heart failure patients.
Why the study?
Despite therapeutic improvements, people with CVD lack support for monitoring and managing their condition at home, where smart home technologies have potential to support care.
What Smart Home Technologies are available for monitoring and managing cardiovascular diseases, and what is their user acceptance?
Systematic Review (n=5)
What Smart Home Technologies are available for monitoring and managing cardiovascular diseases, and what is their user acceptance?
A systematic review found limited availability of Smart Home Technologies for cardiovascular disease management, with the few existing studies focusing exclusively on heart failure patients.
Answers are grounded in this paper and cite their sources.
Smart home technologies remain unavailable for most cardiovascular patients; leaves open a major gap for development and testing beyond heart failure.
Cardiovascular diseases (CVD) are the leading cause of mortality globally. Despite improvement in therapies, people with CVD lack support for monitoring and managing their condition at home and out of hospital settings. Smart Home Technologies have potential to monitor health status and support people with CVD in their homes. We explored the Smart Home Technologies available for CVD monitoring and management in people with CVD and acceptance of the available technologies to end-users. We systematically searched four databases, namely Medline, Web of Science, Embase, and IEEE, from 1990 to 2020 (search date 18 March 2020). “Smart-Home” was defined as a system using integrated sensor technologies. We included studies using sensors, such as wearable and non-wearable devices, to capture vital signs relevant to CVD at home settings and to transfer the data using communication systems, including the gateway. We categorised the articles for parameters monitored, communication systems and data sharing, end-user applications, regulations, and user acceptance. The initial search yielded 2462 articles, and the elimination of duplicates resulted in 1760 articles. Of the 36 articles eligible for full-text screening, we selected five Smart Home Technology studies for CVD management with sensor devices connected to a gateway and having a web-based user interface. We observed that the participants of all the studies were people with heart failure. A total of three main categories—Smart Home Technology for CVD management, user acceptance, and the role of regulatory agencies—were developed and discussed. There is an imperative need to monitor CVD patients’ vital parameters regularly. However, limited Smart Home Technology is available to address CVD patients’ needs and monitor health risks. Our review suggests the need to develop and test Smart Home Technology for people with CVD. Our findings provide insights and guidelines into critical issues, including Smart Home Technology for CVD management, user acceptance, and regulatory agency’s role to be followed when designing, developing, and deploying Smart Home Technology for CVD.
No takes yet. Share an insight, caveat, or question.
Moses et al. (2022) conducted a systematic review in Cardiovascular diseases (heart failure) (n=5). Smart Home Technologies was evaluated on Smart Home Technology for CVD management, user acceptance, and the role of regulatory agencies. A systematic review of 5 studies found limited Smart Home Technology available for cardiovascular disease management, with all included studies focusing exclusively on heart failure patients.
Synapse has enriched 10 related papers. Consider them for comparative context: